These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 15382088

  • 1. Autoregulation of the N-myc gene is operative in neuroblastoma and involves histone deacetylase 2.
    Kim MK, Carroll WL.
    Cancer; 2004 Nov 01; 101(9):2106-15. PubMed ID: 15382088
    [Abstract] [Full Text] [Related]

  • 2. Autoregulation of the human N-myc oncogene is disrupted in amplified but not single-copy neuroblastoma cell lines.
    Sivak LE, Tai KF, Smith RS, Dillon PA, Brodeur GM, Carroll WL.
    Oncogene; 1997 Oct 16; 15(16):1937-46. PubMed ID: 9365240
    [Abstract] [Full Text] [Related]

  • 3. HIF-1alpha induces MXI1 by alternate promoter usage in human neuroblastoma cells.
    Löfstedt T, Fredlund E, Noguera R, Navarro S, Holmquist-Mengelbier L, Beckman S, Påhlman S, Axelson H.
    Exp Cell Res; 2009 Jul 01; 315(11):1924-36. PubMed ID: 19254710
    [Abstract] [Full Text] [Related]

  • 4. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression.
    Alland L, Muhle R, Hou H, Potes J, Chin L, Schreiber-Agus N, DePinho RA.
    Nature; 1997 May 01; 387(6628):49-55. PubMed ID: 9139821
    [Abstract] [Full Text] [Related]

  • 5. Transforming pathways unleashed by a HDAC2 mutation in human cancer.
    Ropero S, Ballestar E, Alaminos M, Arango D, Schwartz S, Esteller M.
    Oncogene; 2008 Jun 26; 27(28):4008-12. PubMed ID: 18264134
    [Abstract] [Full Text] [Related]

  • 6. Mxi1-SRalpha: a novel Mxi1 isoform with enhanced transcriptional repression potential.
    Dugast-Darzacq C, Pirity M, Blanck JK, Scherl A, Schreiber-Agus N.
    Oncogene; 2004 Nov 25; 23(55):8887-99. PubMed ID: 15467743
    [Abstract] [Full Text] [Related]

  • 7. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
    Marcotte R, Chen JM, Huard S, Wang E.
    J Cell Biochem; 2005 Dec 01; 96(5):1071-85. PubMed ID: 16167342
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells.
    Fan L, Iyer J, Zhu S, Frick KK, Wada RK, Eskenazi AE, Berg PE, Ikegaki N, Kennett RH, Frantz CN.
    Cancer Res; 2001 Feb 01; 61(3):1073-9. PubMed ID: 11221835
    [Abstract] [Full Text] [Related]

  • 9. Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells.
    Li H, Wu X.
    Biochem Biophys Res Commun; 2004 Nov 12; 324(2):860-7. PubMed ID: 15474507
    [Abstract] [Full Text] [Related]

  • 10. MBP-1 physically associates with histone deacetylase for transcriptional repression.
    Ghosh AK, Steele R, Ray RB.
    Biochem Biophys Res Commun; 1999 Jul 05; 260(2):405-9. PubMed ID: 10403782
    [Abstract] [Full Text] [Related]

  • 11. In vivo regulation of single copy and amplified N-myc in human neuroblastoma cells.
    Lutz W, Schwab M.
    Oncogene; 1997 Jul 17; 15(3):303-15. PubMed ID: 9233765
    [Abstract] [Full Text] [Related]

  • 12. The zinc finger repressor, ZBP-89, recruits histone deacetylase 1 to repress vimentin gene expression.
    Wu Y, Zhang X, Salmon M, Zehner ZE.
    Genes Cells; 2007 Aug 17; 12(8):905-18. PubMed ID: 17663720
    [Abstract] [Full Text] [Related]

  • 13. The histone deacetylase inhibitor trichostatin A downregulates human MDR1 (ABCB1) gene expression by a transcription-dependent mechanism in a drug-resistant small cell lung carcinoma cell line model.
    El-Khoury V, Breuzard G, Fourré N, Dufer J.
    Br J Cancer; 2007 Aug 20; 97(4):562-73. PubMed ID: 17667922
    [Abstract] [Full Text] [Related]

  • 14. Repression by the Mad(Mxi1)-Sin3 complex.
    Schreiber-Agus N, DePinho RA.
    Bioessays; 1998 Oct 20; 20(10):808-18. PubMed ID: 9819568
    [Abstract] [Full Text] [Related]

  • 15. Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effects.
    Marshall GM, Gherardi S, Xu N, Neiron Z, Trahair T, Scarlett CJ, Chang DK, Liu PY, Jankowski K, Iraci N, Haber M, Norris MD, Keating J, Sekyere E, Jonquieres G, Stossi F, Katzenellenbogen BS, Biankin AV, Perini G, Liu T.
    Oncogene; 2010 Nov 04; 29(44):5957-68. PubMed ID: 20697349
    [Abstract] [Full Text] [Related]

  • 16. An inactivating mutation in HDAC2 leads to dysregulation of apoptosis mediated by APAF1.
    Hanigan CL, Van Engeland M, De Bruine AP, Wouters KA, Weijenberg MP, Eshleman JR, Herman JG.
    Gastroenterology; 2008 Nov 04; 135(5):1654-1664.e2. PubMed ID: 18834886
    [Abstract] [Full Text] [Related]

  • 17. Cell type-specific expression and negative regulation by retinoic acid of the human N-myc promoter in neuroblastoma cells.
    Wada RK, Seeger RC, Reynolds CP, Alloggiamento T, Yamashiro JM, Ruland C, Black AC, Rosenblatt JD.
    Oncogene; 1992 Apr 04; 7(4):711-7. PubMed ID: 1565467
    [Abstract] [Full Text] [Related]

  • 18. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y, Brena RM, Hackanson B, Morrison C, Otterson GA, Plass C.
    J Natl Cancer Inst; 2006 Mar 15; 98(6):396-406. PubMed ID: 16537832
    [Abstract] [Full Text] [Related]

  • 19. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y, Fatima N, Dufau ML.
    Mol Cell Biol; 2005 Sep 15; 25(18):7929-39. PubMed ID: 16135786
    [Abstract] [Full Text] [Related]

  • 20. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
    Law AY, Lai KP, Lui WC, Wan HT, Wong CK.
    Exp Cell Res; 2008 Oct 01; 314(16):2975-84. PubMed ID: 18652825
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.